The Amenorrhea Debate: Exploring Alternative Patient Goals for Endometrial Ablation Webinar

On-Demand Webinar
HCP Resources Page
image
Description
In this on-demand webinar, three industry-leading GYNs unpack the evolving landscape of endometrial ablation and its implications for OBGYN practices. With a focus on patient-centered goals and optimal outcomes, the experts discuss possible unintended consequences of heat-based ablations. Walk away with a deeper understanding of endometrial ablation methods and actionable next steps for integrating cryoablation into your practice.

Key Takeaways
  1. Rethinking Patient Goal Discussions: Experts explore how to keep the patient experience front and center during and after treatment to ensure that patient and clinical needs are met. They discuss how cryotherapy enables GYNs to effectively meet patient goals for treatment, and tips for holding treatment-based conversations with patients.
  2. Possible Unintended Consequences of Heat-Based Ablation: Intracavitary scarring, adhesions and contracture inside the uterus are an expected part of the healing process post-heat-based ablation due to the way heat-based thermal ablation destroys the endometrium.1 The experts discuss the possible unintended consequences and how cryotherapy minimizes these outcomes to help preserve the uterine cavity.
  3. Offering a Highly Satisfactory Ablation Experience for Patients: The webinar concludes with an in-depth discussion of cryotherapy as an alternative endometrial ablation method. The speakers share how the freezing technology provides a highly satisfactory patient experience due to its tolerability, quick recovery time, and reduction of heavy menstrual bleeding and dysmenorrhea.
References:
1 Blog - Preserving Cavity Access After an Endometrial Ablation and Why It Matters: https://cerene.com/preserving-cavity-access-after-an-endometrial-ablation-and-why-it-matters/
Complete the Form Below to View
Now Playing
Video Library
Barbara Levy, MD moderates a discussion with Leslie Hansen Lindner, MD and Taraneh Shirazian, MD as they explore how physicians can achieve patient goals and utilize cryotherapy as a satisfactory alternative endometrial ablation method.
Rhonda Schafer-McLean, MD and her patient, Brooke, discuss how and why the Cerene Cryotherapy Device was the right treatment option for Brooke’s heavy menstrual bleeding symptoms.
GYN experts, Taraneh Shirazian, MD, Richard Salter, MD and Barbara Levy, MD, explore how women’s health professionals can make heavy menstrual bleeding care more patient-centered with new innovations in cryotherapy.
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More